Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods

BMC Research Notes

Volumn 8, Issue 1, 2015, Pages

  Bourmaud, Aurélie ^a,b   Henin, Emilie ^a   Tinquaut, Fabien ^b   Regnier, Véronique ^b   Hamant, Chloé ^b   Colomban, Olivier ^a   You, Benoit ^a,c   Ranchon, Florence ^a,d   Guitton, Jérôme ^a,e   Girard, Pascal ^a   Freyer, Gilles ^a,c   Tod, Michel ^a   Rioufol, Catherine ^a,d   Trillet Lenoir, Véronique ^a,c   Chauvin, Franck ^a,b,f  

^a UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Hospices Civil de Lyon   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ JEAN MONNET   (France)

Author keywords

Adherence; Adverse events; Capecitabine; Oral chemotherapy; Profiles; Quantitative qualitative mixed method

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE;

AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; QUALITATIVE RESEARCH;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CAPECITABINE; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUALITATIVE RESEARCH;

EID: 84936935414     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-015-1231-8     Document Type: Article

References (21)

1. Walter T, Wang L, Chuk K, Ng P, Tannock IF, Krzyzanowska MK (2013) Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine. J Oncol Pharm Pract 20:249-256
2. Bhattacharya D, Easthall C, Willoughby KA, Small M, Watson S (2012) Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract 18:333-342
3. Partridge AH, Archer L, Kornblith AB, Gralow J, Grenier D, Perez E et al (2010) Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol 28:2418-2422
4. Uematsu T, Nakashima M, Fujii M, Hamano K, Yasutomi M, Kodaira S et al (1996) Measurement of 5-fluorouracil in scalp hair: a possible index of patient compliance with oral adjuvant chemotherapy. Eur J Clin Pharmacol 50:109-113
5. Macintosh PW, Pond GR, Pond BJ, Leung V, Siu LL (2007) A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. Eur J Cancer Care (Engl) 16:380-386
6. Mayer EL, Partridge AH, Harris LN, Gelman RS, Schumer ST, Burstein HJ et al (2009) Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat 117:615-623
7. Simons S, Ringsdorf S, Braun M, Mey UJ, Schwindt PF, Ko YD et al (2011) Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 19:1009-1018
8. Spoelstra SL, Given BA, Given CW, Grant M, Sikorskii A, You M et al (2013) An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: an exploratory study. Cancer Nurs 36:18-28
9. Krolop L, Ko Y-D, Schwindt PF, Schumacher C, Fimmers R, Jaehde U (2013) Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study. BMJ Open 3:7
10. Winterhalder R, Hoesli P, Delmore G, Pederiva S, Bressoud A, Hermann F et al (2011) Self-reported compliance with capecitabine: findings from a prospective cohort analysis. Oncology 80:29-33
11. Decker V, Spoelstra S, Miezo E, Bremer R, You M, Given C et al (2009) A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents. Cancer Nurs 32:E20-E29
12. Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59:56-66
13. Thivat E, Van Praagh I, Belliere A, Mouret-Reynier MA, Kwiatkowski F, Durando X et al (2013) Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors. Oncology 84:67-74
14. Bassan F, Peter F, Houbre B, Brennstuhl MJ, Costantini M, Speyer E et al (2014) Adherence to oral antineoplastic agents by cancer patients: definition and literature review. Eur J Cancer Care (Engl) 23:22-35
15. Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S et al (2010) Medication errors involving oral chemotherapy. Cancer 116:2455-2464
16. Regnier Denois V, Poirson J, Nourissat A, Jacquin J-P, Guastalla JP, Chauvin F (2011) Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. Eur J Cancer Care 20:520-527
17. Patel K, Foster NR, Farrell A, Le-Lindqwister NA, Mathew J, Costello B et al (2013) Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature. J Cancer Educ 28:770-776
18. Spoelstra SL, Given BA, Given CW, Grant M, Sikorskii A, You M et al (2013) Issues related to overadherence to oral chemotherapy or targeted agents. Clin J Oncol Nurs 17:604-609
19. Who Working Group (1988) Therapeutic Patient Education Continuing Education Programmes for Health Care Providers in the Field of Prevention of Chronic Diseases. WHO Regional Office for Europe, Copenhague
20. Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6 Suppl):21-24
21. Chau I, Legge S, Fumoleau P (2004) The vital role of education and information in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs 8(Suppl 1):S41-S53